Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE asks Roche for RoActemra cost data

March 5, 2010
Sales and Marketing RoActemra, Roche

Roche’s attempts to secure NICE approval for rheumatoid arthritis drug RoActemra have hit another hurdle. NICE’s independent appraisal committee has …

News

Merck appoints Bridgette Heller

March 5, 2010
Sales and Marketing Merck, appointment, consumer healthcare, sales and marketing

Bridgette Heller has joined Merck & Co as executive vice president and president, consumer health care. She moves to Merck …

Appointment
FPA logo

Just teams up with sexual health charity

March 5, 2010
Medical Communications FPA, charity, contraception, just health pr

Just Health PR is providing PR support for the launch of a new UK consumer book on contraception from sexual …

News

Kantar Health promotes Ceri Thomas

March 4, 2010
Sales and Marketing Kantar Health, appointment, sales and marketing

Ceri Thomas has been promoted to head of global marketing at healthcare consultancy and marketing insights company Kantar Health. In …

Appointment

Pfizer suffers Alzheimer’s setback

March 4, 2010
Research and Development Alzheimer's, Medivation, Pfizer

Pfizer has suffered a big setback with the oral Alzheimer’s disease treatment it is developing with biotech outfit Medivation. Investigational …

News
HCA report

HCA: Five years of change in healthcare communications

March 4, 2010
Medical Communications HCA, industry reputation

In 2005 the Healthcare Communications Association (HCA) conducted its first ever benchmarking survey, exploring trends in the provision of communications …

Feature
Andreotti

Lamberto Andreotti new head of Bristol-Myers Squibb

March 4, 2010
Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …

Appointment
Mario Nacinovich

Axon expands in the US

March 4, 2010
Medical Communications Axon, medical communications

Surrey, UK-based Axon Communications has appointed Mario Nacinovich as managing director of its new US operations. Nacinovich will be based …

News

Stem cell therapy helps diabetes limb problems

March 3, 2010
Research and Development ReNeuron, diabetes, stem cell

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …

News
UCB

Generic Keppra hits UCB sales

March 3, 2010
Sales and Marketing 2009 financials, Keppra, UCB

UCB’s sales fell 13% in 2009 as the pharma company faced the first full year of generic competition in the …

News

Funds keep Archimedes Pharma buoyant

March 3, 2010
Research and Development Archimedes, funding

Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …

News
Dementia strategy

Awareness push for dementia

March 3, 2010
dementia, disease awareness campaigns

The government’s offensive on dementia has continued with a new awareness campaign called Living Well, which aims to break down …

News

UK hit hard as AstraZeneca reveals R&D cuts

March 3, 2010
Research and Development AstraZeneca, job cuts

Nearly 3,500 R&D jobs will be affected at AstraZeneca in the coming months as the pharmaceutical giant exits discovery research …

News
OgilvyAdrianKemsley

Adrian Kemsley joins Ogilvy Healthworld

March 3, 2010
Medical Communications Ogilvy, appointment, medical communications, ogilvy healthworld advertising

Ogilvy Healthworld Advertising has appointed Adrian Kemsley as creative director and overall lead for the agency and unveiled a new …

Appointment

Dr Olaf Stange to head up Bayer Technology in Singapore

March 3, 2010
Manufacturing and Production Bayer Technology Services, appointment, manufacturing and production

Bayer has appointed Dr Olaf Stange to head up its new Southeast Asia regional office for Bayer Technology Services (BTS) …

Appointment

Stability data issue holds up Adventrx cancer drug

March 3, 2010
Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine

US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …

News
Blog footer

Digital Pharma: AZ outlines its online principles

March 2, 2010
Medical Communications FDA, digital pharma, social media

AstraZeneca says it has an obligation to use social media to help empower patients and prescribers to make informed decisions …

Feature
OSI Pharmaceuticals

Astellas moves in on OSI Pharmaceuticals

March 2, 2010
Sales and Marketing Astellas, Astellas Pharma Europe, OSI

Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …

News

Warner Chilcott sees major jump in revenue

March 2, 2010
P&G, Warner Chilcott

Warner Chilcott saw a big increase in 2009 revenue thanks to its acquisition of Proctor and Gamble’s branded pharmaceuticals business. …

News

Merck shows off expanded pipeline

March 2, 2010
Sales and Marketing Merck, Schering-Plough

Merck has put its new pipeline on display for the first time since its October merger with Schering-Plough was completed. …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026